CPT vs XENE · P/E 104, rev $5.3M vs $2.55B cap
Camden Property Trust (CPT) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. XENE currently screens at market cap $2.55B.
Not investment advice. Open the CPT and XENE stock pages for the full models.
Not investment advice.